Schoelwer, Melissa J.
DeBoer, Mark D.
Breton, Marc D.
Funding for this research was provided by:
NIH NIDDK (U01DK127551)
Article History
Received: 19 March 2024
Accepted: 23 May 2024
First Online: 12 July 2024
Funding
: All authors are funded by grant U01DK127551 from NIH NIDDK.
: MJS reports research funding, paid to her university, from Tandem Diabetes Care and Insulet. MDD reports research funding paid to his university from Dexcom Inc, Tandem Diabetes Inc and Medtronic. MDB reports research funding paid to his university from Dexcom, Tandem Diabetes Care and Novo Nordisk, and non-financial research support from Tandem Diabetes Care and Dexcom. Additionally, MDB has a number of patents with royalties licensed to Dexcom, Sanofi, Tandem Diabetes Care and Novo Nordisk. MDB finally reports consulting/speakership activities with Dexcom, Tandem Diabetes Care, Roche, Portal Insulin LLC, BoydSense and Vertex.
: All authors were responsible for drafting this review article and reviewing it critically for important intellectual content. All authors approved the version to be published.